Read the history in context
Records, not a safety rating.
Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.
View source coverage →Severity Breakdown
Class I — Serious
0Class II — Moderate
1Class III — Low Risk
0Categories
MEDICATION
Recall Timeline
Class IIFDAJun 10, 2026
McKesson — Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01 Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Track McKesson recalls automatically
Get an alert when a matching McKesson recall turns up.
Start Free Trial